Commentary Open Access
Volume 1 | Issue 2 | DOI: https://doi.org/10.33696/Signaling.1.010
Novel Hippocampal Interaction between Spexin and Corticotropin Releasing Factor
Jin Bai1,*, Chengyuan Lin2
- 1Department of Obstetrics and Gynecology, University of California Irvine, Irvine, California, USA
- 2Lab of Brain and Gut Research, School of Chinese Medicine, Hong Kong Baptist University, Kowloon Tong, Hong Kong SAR, China
Corresponding Author
Jin Bai, baij3@hs.uci.edu
Received Date: May 20, 2020
Accepted Date: June 11, 2020
Bai J, Lin C. Novel Hippocampal Interaction between Spexin and Corticotropin Releasing Factor. J Cell Signal 2020;1(2):38-41.
Copyright: © 2020 Bai J, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Recommended Articles
Novel Hippocampal Interaction between Spexin and Corticotropin Releasing Factor
Nowadays, people pay more and more attention to homeostatic regulation, which is the detrimental effect of stress on physiological and psychological well-being and cannot be ignored. The public perception of anxiety has been associated with the hypothalamic hormones, because of the pivotal role of the hypothalamic-pituitaryadrenal axis to promote the pituitary-adrenal functions and endocrine responses.
Is Cellular Senescence of Dopaminergic Neurons the Cause of Local Inflammation in the Midbrain Observed in Parkinson’s Disease?
Current research investigating the pathomechanisms of neurodegenerative disorders of the central nervous system (CNS), such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS), or Parkinson’s disease (PD), led to the understanding that these diseases have to be seen in the context of immune responses [1]. In other words,
Insulin-like Growth Factor 2: Beyond its Role in Hippocampal-dependent Memory
The insulin-like peptides family is composed of insulin, insulin-like growth factor 1 (IGF1), and insulin-like growth factor (IGF2), together with IGF binding proteins (IGFBP1- IGFBP6) [1]. IGF2 is a single-chain secreted protein of 67 amino acids with important functions in fetal growth and development. IGF2 is the less characterized member of this family, and in mice and rats its expression in the brain occurs during embryonic development and adulthood but declines during aging [2].
Differentiation and Subtype Specification of Enteric Neurons: Current Knowledge of Transcription Factors, Signaling Molecules and Signaling Pathways Involved
The enteric nervous system is the largest component of the autonomic nervous system. It contains a broad network of interconnected plexuses and enteric neuronal subtypes which are in charge of the normal functioning of the gastrointestinal tract. Vagal and sacral neural crest cells are at the basis of the enteric nervous system development. These cells undergo multiple processes such as migration, proliferation and differentiation to finally form a functional enteric nervous system.
Association of Conformationally Altered Tau with α-1-antichymotrypsin in the Nuclei of Neurons in the Alzheimer's Disease Brain
Conformational changes of Tau have been described to occur during its fibrillary and non-fibrillary aggregation inside neurons affected in the brain of Alzheimer’s disease (AD) patients. Two consecutive conformations have been described during the progression of the disease: an early conformation detected with the Alz-50 antibody, recognizing Tau molecules folding its amino terminus over its third repeated domain, and a later conformation involving the bending of the proline-rich region over the third repeated domain.